PharMerica Co. (NYSE:PMC) CEO Gregory S. Weishar sold 521,089 shares of the firm’s stock in a transaction on Thursday, December 7th. The shares were sold at an average price of $29.25, for a total transaction of $15,241,853.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
PharMerica Co. (NYSE:PMC) traded up $0.05 during midday trading on Friday, reaching $29.25. 1,371,600 shares of the company’s stock traded hands, compared to its average volume of 283,015. The company has a debt-to-equity ratio of 0.79, a current ratio of 2.58 and a quick ratio of 1.79. The stock has a market capitalization of $910.27, a price-to-earnings ratio of 47.95, a price-to-earnings-growth ratio of 1.27 and a beta of 0.82. PharMerica Co. has a 52 week low of $22.00 and a 52 week high of $29.50.
PharMerica (NYSE:PMC) last posted its quarterly earnings data on Thursday, November 9th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.03). The firm had revenue of $595.10 million for the quarter, compared to analysts’ expectations of $596.80 million. PharMerica had a return on equity of 2.30% and a net margin of 0.54%. research analysts anticipate that PharMerica Co. will post 1.92 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Allianz Asset Management GmbH lifted its position in shares of PharMerica by 3,347.4% during the third quarter. Allianz Asset Management GmbH now owns 399,591 shares of the company’s stock worth $11,708,000 after purchasing an additional 388,000 shares during the last quarter. Royce & Associates LP lifted its position in shares of PharMerica by 966.5% during the second quarter. Royce & Associates LP now owns 426,600 shares of the company’s stock worth $11,198,000 after purchasing an additional 386,600 shares during the last quarter. Victory Capital Management Inc. lifted its position in shares of PharMerica by 40.1% during the second quarter. Victory Capital Management Inc. now owns 1,294,142 shares of the company’s stock worth $33,971,000 after purchasing an additional 370,266 shares during the last quarter. SG Americas Securities LLC lifted its position in shares of PharMerica by 3,799.6% during the third quarter. SG Americas Securities LLC now owns 281,007 shares of the company’s stock worth $8,234,000 after purchasing an additional 273,801 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in shares of PharMerica during the third quarter worth $7,031,000. 89.97% of the stock is owned by institutional investors.
A number of research analysts recently weighed in on the stock. Zacks Investment Research lowered shares of PharMerica from a “buy” rating to a “hold” rating in a report on Wednesday, October 4th. ValuEngine lowered shares of PharMerica from a “buy” rating to a “hold” rating in a research note on Friday, September 22nd. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $30.50.
PharMerica Company Profile
Receive News & Ratings for PharMerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharMerica and related companies with MarketBeat.com's FREE daily email newsletter.